234 related articles for article (PubMed ID: 16820227)
1. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism.
Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y
Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227
[TBL] [Abstract][Full Text] [Related]
2. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
[TBL] [Abstract][Full Text] [Related]
5. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
[TBL] [Abstract][Full Text] [Related]
7. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
8. The melanocortin system in Fugu: determination of POMC/AGRP/MCR gene repertoire and synteny, as well as pharmacology and anatomical distribution of the MCRs.
Klovins J; Haitina T; Fridmanis D; Kilianova Z; Kapa I; Fredriksson R; Gallo-Payet N; Schiöth HB
Mol Biol Evol; 2004 Mar; 21(3):563-79. PubMed ID: 14694081
[TBL] [Abstract][Full Text] [Related]
9. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
[TBL] [Abstract][Full Text] [Related]
10. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
11. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the potent cyclic and linear melanocortin analogues.
Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
[TBL] [Abstract][Full Text] [Related]
13. Inverse agonist activity of agouti and agouti-related protein.
Chai BX; Neubig RR; Millhauser GL; Thompson DA; Jackson PJ; Barsh GS; Dickinson CJ; Li JY; Lai YM; Gantz I
Peptides; 2003 Apr; 24(4):603-9. PubMed ID: 12860205
[TBL] [Abstract][Full Text] [Related]
14. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
Yang Z; Tao YX
Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
[TBL] [Abstract][Full Text] [Related]
15. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
[TBL] [Abstract][Full Text] [Related]
16. Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation.
Patten CS; Daniels D; Suzuki A; Fluharty SJ; Yee DK
Regul Pept; 2007 Aug; 142(3):111-22. PubMed ID: 17376547
[TBL] [Abstract][Full Text] [Related]
17. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
18. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
